LTA/TNF-β Cancer Research Results

LTA/TNF-β, LTA / TNF-β / lymphotoxin-α: Click to Expand ⟱
Source:
Type:
Tumor Necrosis Factor-beta (TNF-β), also known as Lymphotoxin-alpha (LT-α), is a cytokine involved in systemic inflammation and one of the cytokines that make up the tumor necrosis factor family.
TNF-β is typically high expression in cancers with poor prognosis.
Field Suggested Entry
Target LTA / lymphotoxin-α / TNF-β
Full Name Lymphotoxin alpha
Target Class TNF-superfamily cytokine
Main Receptors TNFR1/TNFRSF1A, TNFR2/TNFRSF1B, HVEM/TNFRSF14; LTBR/TNFRSF3 when complexed with LTB
Primary Biology Lymphocyte-derived inflammatory signaling, immune activation, antiviral response, apoptosis signaling, lymphoid tissue organization, secondary lymphoid organ development
Cancer Relevance Medium and context-dependent: may contribute to tumor-cell cytotoxicity, cancer immunity, lymphoid-structure formation, chronic inflammation, and tumor microenvironment remodeling depending on context
AD Relevance Low-medium: indirect relevance through TNF-family neuroinflammation; less established than TNF-α, TNFR1, or TNFR2
Therapeutic Direction Context-dependent. Suppress excessive/pathological inflammatory signaling where appropriate, but avoid assuming that LTA inhibition is always beneficial because lymphotoxin signaling can also support immune defense and tumor surveillance.


Scientific Papers found: Click to Expand⟱
1304- ASA,    Aspirin Inhibits Colorectal Cancer via the TIGIT-BCL2-BAX pathway in T Cells
- in-vitro, CRC, NA - in-vivo, NA, NA
TumCP↓,
Apoptosis↑,
Bcl-2↓,
BAX↑,
IL10↓,
LTA/TNF-β↓, transforming growth factor-β1

3320- SIL,    Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action
- Review, AD, NA
*hepatoP↑, Apart from the hepatoprotective nature, which is mainly due to its antioxidant and tissue regenerative properties,
*neuroP↑, Silymarin has recently been reported to be a putative neuroprotective agent against many neurologic diseases including Alzheimer's and Parkinson's diseases, and cerebral ischemia
*ROS↓, capacity to inhibit oxidative stress in the brain,
*β-Amyloid↓, additional advantages by influencing pathways such as β‐amyloid aggregation, inflammatory mechanisms, cellular apoptotic machinery, and estrogenic receptor mediation.
*Inflam↓,
*Aβ↓, Silymarin on inhibition of Aβ fibril formation and aggregation in animal and cellular models of AD
*NF-kB↓, By inhibiting the production of inflammatory agents such as NF‐κB, TNF‐α, TNF‐β, iNOS, NO, COX, Silymarin impedes neuroinflammation
*TNF-α↓,
*LTA/TNF-β↓,
*iNOS↓,
*NO↓,
*COX2↓,


Showing Research Papers: 1 to 2 of 2

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death(tgid=5) ⓘ

Apoptosis↑, 1,   BAX↑, 1,   Bcl-2↓, 1,  

Migration(tgid=13) ⓘ

TumCP↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL10↓, 1,   LTA/TNF-β↓, 1,  
Total Targets: 6

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

ROS↓, 1,  

Cell Death(tgid=5) ⓘ

iNOS↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2↓, 1,   Inflam↓, 1,   LTA/TNF-β↓, 1,   NF-kB↓, 1,   TNF-α↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,   β-Amyloid↓, 1,  

Functional Outcomes(tgid=23) ⓘ

hepatoP↑, 1,   neuroP↑, 1,  
Total Targets: 12

Scientific Paper Hit Count for: LTA/TNF-β, LTA / TNF-β / lymphotoxin-α
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:914  State#:%  Dir#:1
  wNotes=on  sortOrder:rid,rpid

 

Home Page